Publications by authors named "Marie Mayenga"

Claim this Profile
T
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer.
Marie Mayenga, Ana Rita Pedroso, Marion Ferreira, Thomas Gille, Maria Joana Pereira Catarata

Breathe (Sheff)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie

Lung Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued.
Marie Mayenga, Nicolas Falvo, Isabelle Mahé, Anne-Sophie Jannot, Benoit Gazeau

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Jamila Talb, Paul Takam Kamga, Marie Mayenga, Adrien Costantini, Catherine Julié

Cancer Immunol Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases.
Marie Mayenga, Jean-Baptiste Assié, Isabelle Monnet, Marie-Ange Massiani, Laure Tabeze

Lung Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lorlatinib - Induced pulmonary arterial hypertension.
Alexandre Chabrol, Marie Mayenga, Abdul Momen Hamid, Sylvie Friard, Hélène Salvator

Lung Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis